Institute of Health and Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, England, UK.
BMC Cancer. 2010 Jul 6;10:357. doi: 10.1186/1471-2407-10-357.
There is a paucity of recent epidemiological data on bone cancers. The aim of this study was to describe incidence and survival patterns for bone cancers diagnosed during 1981 - 2002.
Cases aged 0 - 39 years (236 osteosarcomas, 166 Ewing sarcomas and 73 chondrosarcomas) were analysed using Poisson and Cox regressions.
Incidence rates (per million persons per year) for osteosarcoma were 2.5 at age 0 - 14 years; 4.5 at age 15 - 29 years and 1.0 at age 30 - 39 years. Similarly, for Ewing sarcoma the incidence rates were 2.2; 2.9; 0.4 and for chondrosarcoma rates were 0.1; 1.2; 1.8 respectively. Incidence of osteosarcoma increased at an average annual rate of 2.5% (95% CI 0.4 - 4.7; P = 0.02), but there was no change in incidence of Ewing sarcoma or chondrosarcoma. There was a marginally statistically significant improvement in survival for Ewing sarcoma (hazard ratio (HR) per annum = 0.97; 95% CI 0.94 - 1.00; P = 0.06), although patients aged 15 - 39 years (n = 93) had worse overall survival than those aged 0 - 14 (n = 73; HR = 1.46; 95% CI 0.98 - 2.17; P = 0.06). There was no significant improvement in osteosarcoma survival (HR per annum = 0.98; 95% CI 0.95 - 1.01; P = 0.18).
Reasons for poorer survival in Ewing sarcoma patients aged 15 - 39 years and failure to significantly improve survival for osteosarcoma patients requires further investigation.
关于骨癌,最近的流行病学数据很少。本研究的目的是描述 1981 年至 2002 年间诊断的骨癌的发病和生存模式。
对 0-39 岁患者(236 例骨肉瘤、166 例尤文肉瘤和 73 例软骨肉瘤)进行分析,采用泊松和 Cox 回归。
骨肉瘤的发病率(每百万人口/年)在 0-14 岁年龄组为 2.5;在 15-29 岁年龄组为 4.5;在 30-39 岁年龄组为 1.0。同样,尤文肉瘤的发病率为 2.2;2.9;0.4;软骨肉瘤的发病率为 0.1;1.2;1.8。骨肉瘤的发病率以平均每年 2.5%的速度增长(95%CI 0.4-4.7;P=0.02),但尤文肉瘤或软骨肉瘤的发病率没有变化。尤文肉瘤的生存率略有统计学意义的改善(每年危险比(HR)=0.97;95%CI 0.94-1.00;P=0.06),尽管 15-39 岁的患者(n=93)的总体生存率比 0-14 岁的患者(n=73)差(HR=1.46;95%CI 0.98-2.17;P=0.06)。骨肉瘤的生存率没有显著改善(每年 HR=0.98;95%CI 0.95-1.01;P=0.18)。
15-39 岁尤文肉瘤患者生存率较差的原因以及骨肉瘤患者生存率未能显著改善需要进一步调查。